Attributable inpatient costs of recurrent Clostridium difficile infections

Infection Control and Hospital Epidemiology

Volumn 35, Issue 11, 2014, Pages 1400-1407

  Dubberke, Erik R ^a   Schaefer, Eric ^b   Reske, Kimberly A ^a   Zilberberg, Marya ^c,d   Hollenbeak, Christopher S ^b   Olsen, Margaret A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c EviMed Research Group LLC   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; ELECTRONIC MEDICAL RECORD; FEMALE; HEART INFARCTION; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; ICD-9-CM; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODEL; RECURRENT INFECTION; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; SENSITIVITY ANALYSIS; ZERO INFLATED LOGNORMAL MODEL; ECONOMICS; FOLLOW UP; HOSPITAL READMISSION; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PSEUDOMEMBRANOUS COLITIS; RECURRENT DISEASE; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA;

AGED; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; RECURRENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 84908351963     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1086/678428     Document Type: Article

References (25)

1. Garey KW, Sethi S, Yadav Y, Dupont HL. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 2008;70:298–304.
2. Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect 2009;58:403–410.
3. Hebert C, Du H, Peterson LR, Robicsek A. Electronic health record–based detection of risk factors for Clostridium difficile infection relapse. Infect Control Hosp Epidemiol 2013;34:407–414.
4. Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect 2012; 18(suppl 6):21–27.
5. Kim JW, Lee KL, Jeong JB, et al. Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea. World J Gastroenterol 2010;16:3573-3577.
6. Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001;357:189-193.
7. Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med 2010;170:772-778.
8. McFarland LV, Surawicz CM, Rubin MS, et al. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 1999;20:43-49.
9. Pepin J, Alary ME, Valiquette L, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005;40:1591-1597.
10. Pepin J, Routhier S, Gagnon S, Brazeau I. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 2006;42:758-764.
11. Drekonja DM, Amundson WH, Decarolis DD, Kuskowski MA, Lederle FA, Johnson JR. Antimicrobial use and risk for recurrent Clostridium difficile infection. Am J Med 2011;124:1081-1087.
12. Nair S, Yadav D, Corpuz M, Pitchumoni CS. Clostridium difficile colitis: factors influencing treatment failure and relapse—a prospective evaluation. Am J Gastroenterol 1998;93:1873-1876.
13. Moshkowitz M, Ben Baruch E, Kline Z, Shimoni Z, Niven M, Konikoff F. Risk factors for severity and relapse of pseudomembranous colitis in an elderly population. Colorectal Dis 2007;9: 173-177.
14. Petrella LA, Sambol SP, Cheknis A, et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficileBI strain. Clin Infect Dis 2012; 55:351-357.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.
16. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comor-bidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–619.
17. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile– associated disease. Infect Control Hosp Epidemiol 2007;28:140–145.
18. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431–455.
19. Aitchison J. On the distribution of a positive random variable having a discrete probability mass at the origin. J Am Stat Assoc 1955;50:901–908.
20. Cohn TA, DeLong LL. Estimating constituent loads. Water Re-sour Res 1989;25:937–942.
21. Albert JM, Wang W, Nelson S. Estimating overall exposure effects for zero-inflated regression models with application to dental caries. Stat Methods Med Res 2014;23:257–278.
22. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short- and long-term attributable costs of Clostridium difficile– associated disease in nonsurgical inpatients. Clin Infect Dis 2008; 46:497–504.
23. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clos-tridium difficile. Clin Infect Dis 2002;34:346–353.
24. Hogan C, Lunney J, Gabel J, Lynn J. Medicare beneficiaries’ costs of care in the last year of life. Health Aff (Millwood) 2001; 20:188–195.
25. Riley GF, Lubitz JD. Long-term trends in Medicare payments in the last year of life. Health Serv Res 2010;45:565–576.